Showing results (311-320 of 981) with videos related to
Sort By:
Pageof 99
Cardiovascular Therapeutics|May 19, 2017
Endothelial damage effects of circulating microparticles from patients with stable angina are reduced by aspirin through ERK/p38 MAPKs pathwaysGong Cheng, Xue-Feng Shan, Xu-Lang Wang, et al.Cardiovascular Therapeutics|April 3, 2018
microRNA-181a inhibits ocular neovascularization by interfering with vascular endothelial growth factor expressionChun Yang, Houda Tahiri, Chenrongrong Cai, et al.Cardiovascular Therapeutics|July 15, 2018
Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case-control studyLuca Zanella, Giacomo Zoppellaro, Lucia Marigo, et al.Cardiovascular Therapeutics|September 24, 2016
Cytochrome P450 2C9 gene polymorphism and warfarin maintenance dosage in pediatric patients: A systematic review and meta-analysisJinhua Zhang, Lihong Tian, Jinlong Huang, et al.Cardiovascular Therapeutics|April 27, 2017
Aspirin responsiveness changes in obese patients following bariatric surgeryNicholas B Norgard, Scott V Monte, Stanley F Fernandez, et al.Cardiovascular Therapeutics|May 4, 2017
Association of body mass index with mortality in Chinese patients after percutaneous coronary intervention: A large single-center dataHuanhuan Wang, Zhan Gao, Xueyan Zhao, et al.Cardiovascular Therapeutics|January 16, 2010
Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion modelWangde Dai, Sharon L Hale, Gregory L Kay, et al.Cardiovascular Therapeutics|August 28, 2016
Warfarin persistence among atrial fibrillation patients - why is treatment ended?Fredrik Björck, Agnes Ek, Lars Johansson, et al.Cardiovascular Therapeutics|June 7, 2018
Cost-effectiveness analysis of biodegradable polymer versus durable polymer drug-eluting stents incorporating real-world evidenceMonica Teng, Ying Jiao Zhao, Ai Leng Khoo, et al.Cardiovascular Therapeutics|May 31, 2018
Warfarin, but not rivaroxaban, promotes the calcification of the aortic valve in ApoE-/- miceMarcello Rattazzi, Elisabetta Faggin, Elisa Bertacco, et al.Pageof 99